People · Operator

Thomas N. Pedersen

Named in public records as an officer, director or promoter · active 2008–2010 · Other Health Care

1
Companies
2
Filings
$128.9M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Small Bone Innovations IncOther Health CareSeries D+$128.9M$97.8M2008
Operator network

Thomas N. Pedersen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Anthony G. Viscogliosi · 7 companies · 1 sharedAnthony G. Viscog…John J. Viscogliosi · 7 companies · 1 sharedJohn J. Viscoglio…Andrew A. Fink · 2 companies · 1 sharedAndrew A. FinkKenneth S. Abramowitz · 2 companies · 1 sharedKenneth S. Abramo…Thomas A. Crowley, Jr. · 2 companies · 1 sharedThomas A. Crowley…Amirul Fares Bin Wan Zahir · 1 companies · 1 sharedAmirul Fares Bin …Florian D. Kemmerich · 1 companies · 1 sharedFlorian D. Kemmer…James D. Hook · 1 companies · 1 sharedJames D. HookJohn N. Kastanis · 1 companies · 1 sharedJohn N. KastanisSteven D. Ward · 1 companies · 1 sharedSteven D. WardThierry S. Marnay · 1 companies · 1 sharedThierry S. MarnayThomas B. Loring · 1 companies · 1 sharedThomas B. LoringSmall Bone Innovations Inc · $128.9M raisedSmall Bone Innovation…Thomas N. PedersenTP
Thomas N. Pedersen Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Thomas N. Pedersen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
John J. Viscogliosi17
Anthony G. Viscogliosi17
Andrew A. Fink12
Kenneth S. Abramowitz12
Thomas A. Crowley, Jr.12
Amirul Fares Bin Wan Zahir11
Steven D. Ward11
Thomas B. Loring11
John N. Kastanis11
Florian D. Kemmerich11
James D. Hook11
Thierry S. Marnay11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.